Genomic Health

Genomic Health, Inc. is a global leading provider of genomic-based diagnostic tests, helping to optimize cancer care by addressing the overtreatment of diseases, which is one of the biggest issues in today's healthcare. With its OncotypeIQ® genomic intelligence platform, the company leverages its world-class scientific and commercial expertise and infrastructure to transform clinical and genomic big data into actionable outcomes for treatment planning and monitoring throughout the entire cancer patient journey, from diagnosis to treatment selection. Currently, the Oncotype IQ genomic testing and service portfolio includes the company’s flagship series of Oncotype DX gene expression tests, which have been used to guide treatment decisions for more than 750,000 cancer patients worldwide. Genomic Health is expanding its test portfolio to include other liquid- and tissue-based tests, including the recently launched OncotypeSEQ® Liquid Select™ test.